Search results
Exact Sciences Rockets As Guardant's Blood Test Pales Vs. Cologuard
Investor's Business Daily· 1 year agoGuardant Health unveiled pivotal results for its colon cancer-detecting blood test that lagged rival...
Exact Sciences (EXAS) Cologuard Growth Robust Amid Margin Woes
Zacks via Yahoo Finance· 2 years agoExact Sciences' (EXAS) legacy Screening business is growing on impressive Cologuard volume growth...
Exact Sciences (EXAS) Cologuard Business Grows Amid Cost Woes
Zacks via Yahoo Finance· 2 years agoExact Sciences EXAS continues to make significant progress with its Cologuard test. The integration...
Exact Sciences' (EXAS) Solid Cologuard Sales, Innovation Aid
Zacks via Yahoo Finance· 6 months agoExact Sciences EXAS continues to make significant progress with its Cologuard test. New launches...
Exact Sciences (EXAS) to Post Q4 Earnings: What's in Store?
Zacks via Yahoo Finance· 4 months agoExact Sciences' (EXAS) revenues in the fourth quarter of 2023 are likely to have been driven by its...
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
Investor's Business Daily· 2 months agoExact Sciences stock surged to a seven-month high Tuesday after the company's colon cancer-screening...
Exact Sciences (EXAS) Q1 2024 Earnings Call Transcript
Motley Fool via Yahoo Finance· 1 month agoImage source: The Motley Fool. Exact Sciences (NASDAQ: EXAS) Q1 2024 Earnings Call May 08, 2024,...
Exact Sciences, Mayo Clinic share early data on esophageal cancer test
MedTech Dive via Yahoo Finance· 3 months agoDive Brief: Exact Sciences shared early results of a test it is developing with Mayo Clinic to...
Exact Sciences (EXAS) Gains From New Buyouts Amid Rising Costs
Zacks via Yahoo Finance· 9 months agoExact Sciences (EXAS) is improving customer experience by making it simpler to order Cologuard...
Exact Sciences, Guardant Health Put Up Big Sales Beats As They Target The 'Most Preventable' Cancer
Investor's Business Daily· 1 year agoExact Sciences delivered a first-quarter report that "checked all the boxes," an analyst said as...